WebShenzhen Chipscreen Biosciences Co., Ltd. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was CNY 533.46 million … WebShenzhen Chipscreen Biosciences Co., Ltd. is a China-based company principally engaged in the research and development of original innovative molecular entity drugs. The Company specializes in the research and development of original innovative drugs in the three major therapeutic areas of cancer, metabolic diseases and immune diseases.
Did you know?
WebShenzhen Chipscreen Biosciences Co., Ltd., established in March 2001 by a group of senior scientists returned from the United States, is a pioneer in drug innovation and … Formerly Manager of Sales at Nanjing Zhenzhong Biology Engineering Co., Ltd. … Therapeutic Areas. 我们围绕肿瘤、代谢性疾病、自身免疫疾病、中枢神经性疾病 … Innovative Pipelines. As a pioneer and leading player in the development of … 2024.12.01. Licensing Partner of Shenzhen Chipscreen Biosciences - HUYABIO … Shenzhen Chipscreen Biosciences Co., Ltd. (Group Headquarters) 0755-36993500. … 2024.03.20. 股东减持股份计划完成暨减持结果公告 Home; Patient Care; Patient Care; Safety . Patient safety is our top priority. Based … In Chipscreen Biosciences, promotion never goes by seniority. With an employment … WebMar 2, 2024 · HONG KONG, March 1, 2024 /PRNewswire/ --Akeso, Inc. (9926.HK) ("Akeso"), a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide announced that it entered into a collaboration agreement with Shenzhen …
WebStock analysis for Shenzhen Chipscreen Biosciences Co Ltd (688321:Shanghai) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WebApr 7, 2024 · Shenzhen Chipscreen Biosciences Co Ltd is engaged in the research and development of small molecule drugs. Contact No. 10, Gaoxin Zhongyi, Room 601-606, Building 2, ...
WebDec 1, 2024 · Shenzhen Chipscreen Biosciences Co., Ltd. 2024-12-01 21:54 1318. Share: SHENZHEN, China, Dec. 1, 2024 /PRNewswire/ -- Shenzhen Chipscreen Biosciences' licensing partner, HUYABIO International (HUYABIO™), today announced the regulatory approval for Chidamide (Tucidinostat, also known as Epidaza ®, Hiyasta®, HBI-8000) … WebFeb 27, 2024 · Shenzhen Chipscreen Biosciences Co., Ltd. (Stock symbol: 688321.SH) has been listed on the SSE STAR Market on August 12, 2024. About Chipscreen NewWay …
WebMar 23, 2024 · Shenzhen Chipscreen Biosciences Co., Ltd. Registered Shs -A- Stock 28.96 CNY +0.08 +0.28% Official Close 3/23/2024 SHA
WebFeb 27, 2024 · Shenzhen Chipscreen Biosciences Co., Ltd. (Stock symbol: 688321.SH) has been listed on the SSE STAR Market on August 12, 2024. About Chipscreen NewWay Biosciences. computer chair pad for hardwood floorsWebApr 13, 2024 · INDIVIOR PLC: Quotazioni in tempo reale, grafico intraday 5 giorni, variazioni, volumi, indicatori analisi tecnica e storico delle operazioni dell'azione INDIVIOR PLC 2IVB GB00BN4HT335 BOERSE MUENCHEN computer chair repair shop near meWebShenzhen Chipscreen Biosciences. Glassdoor gives you an inside look at what it's like to work at Shenzhen Chipscreen Biosciences, including salaries, reviews, office photos, and … computer chair not recliningWebAge : 64. Linked companies : Jacobio Pharmaceuticals Group Co., Ltd. Summary. Bai Lu is on the board of Jacobio Pharmaceuticals Group Co., Ltd. He received an undergraduate degree from East China Normal University and a doctorate from Cornell University. Current positions of Bai Lu. ecid toolWebA. Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of small molecule drugs. Its products include original medicine such as Chidamide, … computer chair pinkWebAug 23, 2024 · Shenzhen Chipscreen Biosciences Co., Ltd (Chipscreen Biosciences, Shanghai: 688321) was established in March 2001, and has currently become a leading … eci electoral roll searchWebFrontiers in Endocrinology (Jan 2024) . Discovery of a novel, liver-targeted thyroid hormone receptor-β agonist, CS271011, in the treatment of lipid metabolism disorders ecie anesthesia llc